Laboratory and clinical parameters
| KS Testa | Vasogenic Edemac | Cytotoxic Edemac | Pd | |
|---|---|---|---|---|
| Age (yr) | .54b | 40.9 (16.76) | 50.67 (24) | .38 |
| Female | 16 (72) | 6 (100) | .149 | |
| Sodium | .904b | 137.5 (3.4) | 134.8 (5.5) | .54 |
| Potassium | .945b | 4.2 (0.32) | 3.6 (0.32) | .153 |
| Chloridee | .608b | 104.5 (3.92) | 98.2 (7.33) | .07 |
| Calcium | .890b | 2.16 (0.31) | 2.2 (0.23) | .9 |
| Creatinine | .046 | 0.92 (0.66–2.4) | 0.91 (0.62–1.67) | .76 |
| Albuminf | .941b | 29.26 (6.71) | 38.43 (4.2) | .004 |
| Aspartate transaminase | .024 | 45 (24–79) | 32 (21–45) | .22 |
| Alanine aminotransferase | .008 | 23 (10–145) | 23 (18–41) | .98 |
| γ-Glutamyltransferase | .012 | 73 (18–178) | 130 (79–200) | .37 |
| Red blood cells | .718b | 3.61 (0.78) | 4.11 (0.60) | .26 |
| Hemoglobin | .937b | 11 (2.56) | 12 (2.15) | .14 |
| Hematocrit | .985b | 33.16 (7.72) | 36.65 (5.74) | .25 |
| White blood cells | .809b | 11.16 (5.69) | 7.62 (5.11) | .18 |
| Threonine | .957b | 175.03 (110.45) | 202.58 (155.77) | .7 |
| Hypertension | 8 (73) | 3 (75) | .73 | |
| Pregnancy | 7 (44) | 1 (16) | .35 | |
| Immunosuppression | 9 (41) | 2 (33) | .56 | |
| Tumore | 2 (9) | 3 (50) | .05 | |
| Transplantation | 4 (18) | 1 (16) | .72 | |
| Coma, delirium | 17 (90) | 4 (80) | .52 | |
| Seizure | 15 (83) | 4 (80) | .65 | |
| Disturbance of vision | 7 (64) | 3 (60) | .65 | |
| Headachee | 2 (17) | 4 (80) | .03 |
a P value of KS test.
b Normally distributed variables.
c Mean (± SD) for normally distributed variables, median (25%–75% quartile) for variables not normally distributed, or n (%) for nominal variables.
d P values of the Student t test for normally distributed variables, the MWU test for variables not normally distributed, and the χ2 test for paired variables. Significance is indicated as P < .05 and P < .01.
e P < 0.05.
f P < .01.